Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
SEC Accession No. 0001143313-24-000107
Filing Date
2024-10-28
Accepted
2024-10-28 10:05:19
Documents
2
Effectiveness Date
2024-10-28

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 25-NSE  
1 primary_doc.xml 25-NSE 1157
2 ruleprovisionnotice.htm EX-99.25 1984
  Complete submission text file 0001143313-24-000107.txt   5162
Mailing Address 11 Wall Street New York NY 10005
Business Address 11 Wall Street New York NY 10005 212-656-5414
NYSE AMERICAN LLC (Filed by) CIK: 0001143313 (see all company filings)

EIN.: 522127241
Type: 25-NSE

Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Subject) CIK: 0001855485 (see all company filings)

EIN.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE | Act: 34 | File No.: 001-40789 | Film No.: 241399106
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)